B of A Securities Downgrades Charles River to Neutral, Lowers Price Target to $215
Portfolio Pulse from Benzinga Newsdesk
B of A Securities has downgraded Charles River Laboratories from Buy to Neutral and reduced its price target from $250 to $215.
October 02, 2024 | 11:21 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
B of A Securities downgraded Charles River Laboratories from Buy to Neutral, reducing the price target from $250 to $215, indicating a less optimistic outlook.
The downgrade from Buy to Neutral by a major analyst like B of A Securities typically signals a less favorable view on the stock, which can lead to a negative short-term impact on the stock price. The lowered price target further supports this outlook.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100